New cancer drug begins first human safety testing
NCT ID NCT06993116
Summary
This is the first study in humans to test the safety and early effects of an experimental drug called SHR-4712 for people with advanced solid tumors. The main goal is to find a safe dose and understand how the body processes the drug. Fifteen participants will receive the treatment until side effects become too severe or their cancer worsens.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350014, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.